ELVIUM SCIENCES DE LA VIE

ELVIUM SCIENCES DE LA VIE Canadian Trademark Information

Pharmaceutical preparations; pharmaceutical preparations, namely, biopharmaceutical preparations; pharmaceutical preparations, namely, immunotherapeutic preparations; anti-emetic preparations; anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; inhalable anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; bronchodilating pharmaceutical preparations; pharmaceutical preparations for the treatment of insomnia and sleep disorders; opioid antagonist pharmaceutical preparations; pharmaceutical preparations for the treatment of opioid overdose; nasal spray preparations; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders; pharmaceutical preparations for the treatment of nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, cerebral palsy and multiple sclerosis; pharmaceutical preparations for the treatment of psychi...
Classification Information
Class Code: 010 - Medical Instrument Products
Description: Medical and veterinary devices
Class Code: 035 - Advertising, Business & Retail Services
Description: Advertising, marketing, promotional and business
Class Code: 039 - Transportation & Storage Services
Description: Transportation and storage
Class Code: 040 - Treatment & Processing of Materials Services
Description: Treatment of materials
Class Code: 042 - Computer & Software Services & Scientific Services
Description: Computer and scientific
Class Code: 044 - Medical, Beauty & Agricultural Services
Description: Medical and veterinary, beauty, agricultural and forestry
Class Code: 005 - Pharmaceutical Products
Description: Pharmaceuticals and herbicides
Matter History Events
Status Date Record Status Description
2023-10-04 Application published - Registration Pending
2023-10-04 Registration published - Registered
2023-07-12 Application published - Advertised
2023-06-19 National prosecution history entry - Approval Notice Sent
2023-06-19 Application accepted - Approved
2023-02-28 National prosecution history entry - Correspondence Created
2022-04-04 National prosecution history entry - Search Recorded
2022-04-04 National prosecution history entry - Examiner's First Report
2021-11-22 National prosecution history entry - Amendment to Application
2021-01-14 National prosecution history entry - Security Interest Placed
2019-07-31 Filing date accorded - Formalized
2019-07-29 Application filed - Filed
2019-07-29 National prosecution history entry - Created
Word Mark: ELVIUM SCIENCES DE LA VIE
Current Status:
Registration published
LIVE Mark!
10/4/2023
Application Number: 1977906
Filing Date: Monday, July 29, 2019
Filing Place: Canada
Registration Date: Wednesday, October 4, 2023
Registration Number: TMA1200861
Register Type: Primary
Type Of Mark: Trademark
Mark Feature: Word
Use In Commerce: No
Publication Registration: Wednesday, July 12, 2023
Opposition: 7/12/2023 - 7/12/2023
Last Applicant/Owner: *********
**********
***** ****
Correspondent: Not provided
Goods and Services Information
Description:
(1) - Pharmaceutical preparations; pharmaceutical preparations, namely, biopharmaceutical preparations; pharmaceutical preparations, namely, immunotherapeutic preparations; anti-emetic preparations; anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; inhalable anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; bronchodilating pharmaceutical preparations; pharmaceutical preparations for the treatment of insomnia and sleep disorders; opioid antagonist pharmaceutical preparations; pharmaceutical preparations for the treatment of opioid overdose; nasal spray preparations; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders; pharmaceutical preparations for the treatment of nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, cerebral palsy and multiple sclerosis; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; ophthalmic pharmaceutical preparations; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations for the treatment of anaphylactic reactions; drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of osteoarthritic pain
(2) - Pharmaceutical preparations; pharmaceutical preparations, namely, biopharmaceutical preparations; pharmaceutical preparations, namely, immunotherapeutic preparations; anti-emetic preparations; anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; inhalable anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; bronchodilating pharmaceutical preparations; pharmaceutical preparations for the treatment of insomnia and sleep disorders; opioid antagonist pharmaceutical preparations; pharmaceutical preparations for the treatment of opioid overdose; nasal spray preparations; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders; pharmaceutical preparations for the treatment of nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, cerebral palsy and multiple sclerosis; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; ophthalmic pharmaceutical preparations; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations for the treatment of anaphylactic reactions; drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of osteoarthritic pain
(3) - Pharmaceutical preparations, namely, pharmaceutical preparations for the relief of pain; pharmaceutical preparation, namely, bronchodilator; pharmaceutical preparations for the treatment of disorders of the eye; pharmaceutical preparations, namely, biopharmaceutical preparations, namely, biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; anti-emetic preparations; anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations, namely, anaesthetics for surgical use, general anaesthetics, inhalant anaesthetics, local anaesthetics, topical anaesthetics; inhalable anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; bronchodilating pharmaceutical preparations; pharmaceutical preparations for the treatment of insomnia and sleep disorders; opioid antagonist pharmaceutical preparations; pharmaceutical preparations for the treatment of opioid overdose; nasal spray preparations; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders; pharmaceutical preparations for the treatment of nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, cerebral palsy and multiple sclerosis; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; ophthalmic pharmaceutical preparations; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations for the treatment of anaphylactic reactions; drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of osteoarthritic pain
(4) - Inhalers for therapeutic use; inhalers for medical purposes sold empty; medical devices and apparatus for the delivery of anaesthetic, pre-anaesthetic and analgesic substances
(5) - Inhalers for therapeutic use; inhalers for medical purposes sold empty; medical devices and apparatus for the delivery of anaesthetic, pre-anaesthetic and analgesic substances
(6) - Inhalers for therapeutic use; inhalers for medical purposes sold empty; medical devices and apparatus for the delivery of anaesthetic, pre-anaesthetic and analgesic substances
(7) - Production and distribution of pharmaceutical preparations, and medical devices and supplies; sales of pharmaceutical preparations, and medical devices and supplies
(8) - Production and distribution of pharmaceutical preparations, and medical devices and supplies; sales of pharmaceutical preparations, and medical devices and supplies
(9) - Wholesale and online sales of pharmaceutical preparations, and medical devices and supplies
(10) - Custom manufacture of pharmaceutical preparations, and medical devices and supplies
(11) - Research and development in the fields of pharmaceutical preparations, and medical devices and supplies
(12) - Research and development in the fields of pharmaceutical preparations, and medical devices and supplies
(13) - Research and development in the fields of pharmaceutical preparations, and medical devices and supplies
(14) - Providing information to health care providers about pharmaceutical preparations; providing information about the treatment of human diseases and disorders
(15) - Providing information to health care providers about pharmaceutical preparations; providing information about the treatment of human diseases and disorders
(16) - Providing information to health care providers about pharmaceutical preparations; providing information about the treatment of human diseases and disorders, namely insomnia and sleep disorders, diseases and disorders of the central nervous system, nerve diseases and disorders, psychiatric diseases and disorders, cancer
(17) - Providing information to health care providers about pharmaceutical preparations; providing information about the treatment of human diseases and disorders, namely insomnia and sleep disorders, diseases and disorders of the central nervous system, nerve diseases and disorders, psychiatric diseases and disorders, cancer
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!
As seen on